NEW
YORK, Sept. 16, 2024 /PRNewswire/ --
Kuehn Law, PLLC, a shareholder
litigation law firm, is investigating whether certain officers and
directors of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL)
breached their fiduciary duties to shareholders. The investigation
concerns potential self-dealing. Shareholders may be entitled to
damages and corporate governance reforms.
If you are a long-term ZNTL stockholder
please contact Justin Kuehn, Esq. by email
at justin@kuehn.law or call (833) 672-0814. The
consultation and case are free with no obligation to you.
Kuehn Law pays all case costs and
does not charge its investor clients. Shareholders should
contact the firm immediately as there may be limited time to
enforce your rights.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved,
you contribute to the integrity and fairness of the financial
markets. Your investment. Your voice. Your
future.™
For additional information, please visit Shareholder Derivative
Litigation - Kuehn Law.
Attorney advertising. Prior results do not guarantee similar
outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
View original content to download
multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-zentalis-pharmaceuticals-inc-to-contact-law-firm-302249543.html
SOURCE Kuehn Law, PLLC